Kiumars Shahrokh, Ph.D. - Publications
Affiliations: | 2012 | Pharmacology and Toxicology | University of Utah, Salt Lake City, UT |
Area:
Toxicology, General Biophysics, BiochemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2012 | Shahrokh K, Cheatham TE, Yost GS. Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen. Biochimica Et Biophysica Acta. 1820: 1605-17. PMID 22677141 DOI: 10.1016/J.Bbagen.2012.05.011 | 0.507 | |||
2012 | Shahrokh K, Orendt A, Yost GS, Cheatham TE. Quantum mechanically derived AMBER-compatible heme parameters for various states of the cytochrome P450 catalytic cycle. Journal of Computational Chemistry. 33: 119-33. PMID 21997754 DOI: 10.1002/Jcc.21922 | 0.52 | |||
2011 | Thomas KC, Ethirajan M, Shahrokh K, Sun H, Lee J, Cheatham TE, Yost GS, Reilly CA. Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity. The Journal of Pharmacology and Experimental Therapeutics. 337: 400-10. PMID 21343315 DOI: 10.1124/Jpet.110.178491 | 0.434 | |||
2010 | Moore CD, Shahrokh K, Sontum SF, Cheatham TE, Yost GS. Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity. Biochemistry. 49: 9011-9. PMID 20812728 DOI: 10.1021/Bi101139Q | 0.534 | |||
Show low-probability matches. |